iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS was delisted on the 7th of June, 2023.
0 hedge funds and large institutions have $0 invested in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $979K → $0 (-$979K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cetera Advisors
Denver,
Colorado
|
-$550K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$425K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.52K |
JJS Hedge Fund Activity: Q2 2023 in Review
0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) for Q2 2023, worth a combined $0 — down 100% from $979K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of JJS and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Cetera Advisors, exiting entirely with an estimated $550K sold.
- 0 institutional investors held iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) as of Q2 2023, down from 3 in Q1 2023.
- Funds reported $0 of iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN positions in Q2 2023 and 3 closed out, a net change of -3 holders.
- The largest iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN seller in Q2 2023 was Cetera Advisors, an estimated $550K sold.
Based on aggregated 13F filings for Q2 2023.